Trademark: 97213558
Word
KRIYA ONCOLOGY
Status
Dead
Status Code
606
Status Date
Monday, January 1, 2024
Serial Number
97213558
Mark Type
4000
Filing Date
Tuesday, January 11, 2022
Published for Opposition
Tuesday, October 4, 2022
Abandoned Date
Monday, January 1, 2024

Trademark Owner History
Kriya Therapeutics, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders
42 Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders
"ONCOLOGY"

Trademark Events
Jan 2, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 1, 2024
Abandonment - No Use Statement Filed
May 4, 2023
Notice Of Approval Of Extension Request E-Mailed
May 2, 2023
Sou Extension 1 Granted
May 2, 2023
Sou Extension 1 Filed
May 2, 2023
Sou Teas Extension Received
Mar 10, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 10, 2023
Teas Change Of Correspondence Received
Mar 10, 2023
Teas Change Of Owner Address Received
Nov 29, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 4, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2022
Published For Opposition
Sep 14, 2022
Notification Of Notice Of Publication E-Mailed
Aug 30, 2022
Approved For Pub - Principal Register
Aug 30, 2022
Examiner's Amendment Entered
Aug 30, 2022
Notification Of Examiners Amendment E-Mailed
Aug 30, 2022
Examiners Amendment E-Mailed
Aug 30, 2022
Examiners Amendment -Written
Aug 2, 2022
Notification Of Non-Final Action E-Mailed
Aug 2, 2022
Non-Final Action E-Mailed
Aug 2, 2022
Non-Final Action Written
Jul 21, 2022
Assigned To Examiner
Jan 19, 2022
New Application Office Supplied Data Entered
Jan 14, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24